Tom Robinson

Dr Tom Robinson serves as a Lecturer in Chemical Engineering within the School of Engineering at the University of Edinburgh, specializing in the Bioengineering Research Institute. His interdisciplinary work bridges synthetic biology, membrane biophysics, and microfluidics to engineer biomimetic systems.

His core research focuses on:

• Bottom-up Synthetic Biology: Constructing artificial eukaryotic cells with multi-compartment structures using droplet microfluidics and giant lipid vesicles (GUVs) to enable enzymatic cascades for biofuel production and drug delivery applications.
• Lipid Membrane Engineering: Developing model membrane systems (GUVs and nano-vesicles) to isolate and study membrane properties like permeability, fusion dynamics, and ligand interactions without cellular interference.
• Advanced Microfluidics: Designing novel microfluidic platforms for single-cell analysis (cancer cells, magnetotactic bacteria), high-throughput vesicle production, and precision manipulation of biomimetic structures.

Analysis of Dr Robinson's 55+ publications reveals dominant trends in biomimetic membrane systems (42%), synthetic cell engineering (31%), and microfluidic device innovation (27%). His work increasingly integrates multi-omics approaches with physical manipulation techniques, particularly evident in recent studies on magnetotactic bacteria navigation and phase-separated synthetic cells. The research demonstrates strong translational potential in drug delivery and environmental microbiology.

The Robinson Lab employs cutting-edge microscopy including FLIM, confocal, multiphoton, and high-speed imaging to characterize membrane dynamics and cellular interactions. Current projects focus on ESCRT-III protein-mediated vesicle remodeling, magnetic field effects on bacterial motion, and polymerizable emulsion systems for optical applications. The lab maintains active collaborations across bioengineering, microbiology, and materials science disciplines, with significant contributions to the MaxSynBio consortium for bottom-up cell synthesis.